Boule Diagnostics AB - Asset Resilience Ratio

Latest as of June 2025: 4.94%

Boule Diagnostics AB (BOUL) has an Asset Resilience Ratio of 4.94% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr23.00 Million

≈ $2.48 Million USD Cash + Short-term Investments

Total Assets

Skr465.40 Million

≈ $50.08 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Boule Diagnostics AB's Asset Resilience Ratio has changed over time. Check BOUL strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Boule Diagnostics AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BOUL stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr23.00 Million	4.94%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr23.00 Million	4.94%

Asset Resilience Insights

Limited Liquidity: Boule Diagnostics AB maintains only 4.94% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Boule Diagnostics AB Industry Peers by Asset Resilience Ratio

Compare Boule Diagnostics AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Boule Diagnostics AB (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Boule Diagnostics AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.48%	Skr26.43 Million ≈ $2.84 Million	Skr590.20 Million ≈ $63.51 Million	-0.45pp
2023-12-31	4.93%	Skr37.23 Million ≈ $4.01 Million	Skr755.11 Million ≈ $81.26 Million	-1.80pp
2022-12-31	6.73%	Skr51.11 Million ≈ $5.50 Million	Skr759.96 Million ≈ $81.78 Million	+6.49pp
2021-12-31	0.24%	Skr1.36 Million ≈ $146.36K	Skr572.03 Million ≈ $61.56 Million	+1.04pp
2020-12-31	-0.80%	Skr-3.83 Million ≈ $-411.85K	Skr479.71 Million ≈ $51.62 Million	+3.58pp
2019-12-31	-4.38%	Skr-25.70 Million ≈ $-2.77 Million	Skr586.87 Million ≈ $63.16 Million	-2.21pp
2018-12-31	-2.17%	Skr-10.86 Million ≈ $-1.17 Million	Skr500.85 Million ≈ $53.90 Million	-25.98pp
2017-12-31	23.81%	Skr99.16 Million ≈ $10.67 Million	Skr416.49 Million ≈ $44.82 Million	+11.57pp
2016-12-31	12.24%	Skr44.59 Million ≈ $4.80 Million	Skr364.33 Million ≈ $39.21 Million	-30.74pp
2010-12-31	42.98%	Skr88.58 Million ≈ $9.53 Million	Skr206.11 Million ≈ $22.18 Million	--

pp = percentage points

About Boule Diagnostics AB

ST:BOUL Sweden Medical Devices

Market Cap

$15.88 Million

Skr147.57 Million SEK

Market Cap Rank

#25779 Global

#533 in Sweden

Share Price

Skr3.80

Change (1 day)

-0.52%

52-Week Range

Skr3.15 - Skr6.48

All Time High

Skr74.05